BioSpace News Archive

EnLink joins the fight against cardiovascular disease and stroke in North Texas

Lantheus Holdings, Inc. today announced that it has appointed Etienne Montagut as Senior Vice President of Corporate Development, a newly created position in the Company, effective September 4, 2018.

Quidel Corporation announced today that it has received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the United States Food and Drug Administration (FDA) to market its Sofia 2 Lyme FIA

A group of digital influencers from across the country will partner with St. Jude Children’s Research Hospital© for Childhood Cancer Awareness Month, engaging with their followers to build awareness and help end childhood cancer.

CloudLIMS, a Laboratory Information Management System (LIMS), and Confident CannabisTM, a software for labs and all members of the cannabis supply chain, now offer an integrated solution that provides cannabis testing laboratories with a robust testing, analytical, and reporting tool.

Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 20th Annual Global Investment Conference,

Gilead Sciences, Inc. today announced that John F. Milligan PhD, Gilead’s President and Chief Executive Officer; Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer will participate in at the Morgan Stanley Global Healthcare Conference.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved two new HIV-1 medicines:

Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that Steven A. Shallcross, Interim Chief Executive Officer & Chief Financial Officer, will present a corporate overview at the 20th Annual Rodman & Renshaw Global

Healogics®, the wound healing experts, today announced the launch of their newest program: Healogics Specialty Physicians Care Continuum (HSP Care Continuum).